| LIR LIFE SCIENCES CORP. |
| Kanada |
| CA50206C1005 / A41QA9 |
| N790 (Frankfurt) |
| FRA:N790, ETR:N790, N790:GR |
| - |
| - |
|
LIR Life Sciences Corp. is a biopharmaceutical com..
>Volltext.. |
| 36.16 Mio. EUR |
| 35.24 Mio. EUR |
| - |
| -0.27 Mio. EUR |
| -4.17 Mio. EUR |
| -0.85 EUR |
| - |
| - |
| -0.09 Mio. EUR |
| 26.99 |
| - |
| -153.03% |
| - |
| - |
| - |
| - |
| 09.01.26 |
|
||||
|
||||
|